Immunology

Lupus a tough disease to spot, treat

(HealthDay)—Lupus is difficult to diagnose and treat, but scientists are working to learn more about its genetic causes and to develop better treatments.

Arthritis & Rheumatism

Simultaneous diagnosis of SLE, pheochromocytoma described

(HealthDay)—A case of simultaneous diagnosis of systemic lupus erythematous (SLE) and pheochromocytoma, with disappearance of SLE after pheochromocytoma treatment, is described in a letter to the editor published online ...

Diseases, Conditions, Syndromes

Researchers identify enzyme that contributes to development of lupus

Researchers at Beth Israel Deaconess Medical Center (BIDMC) have identified an enzyme that is significantly elevated in mouse models of systemic lupus erythematosus and in blood samples of patients with lupus. Published online ...

Arthritis & Rheumatism

Monash researchers bringing hope to lupus patients

Researchers at Monash University are leading the world's largest study to describe lupus patients and disease characteristics, bringing treat-to-target options for lupus a step closer.

Arthritis & Rheumatism

Listening to lupus

Lupus is a mysterious chronic illness that primarily affects women in their prime of life. In people with lupus, the immune system goes awry, attacking healthy tissue. While there is no cure, there are many options for treatment, ...

Arthritis & Rheumatism

SLICC/ACR criteria don't ID severe internal disease in SCLE

(HealthDay)—Neither the American College of Rheumatology (ACR) nor the Systemic Lupus International Collaborating Clinics (SLICC) criteria distinguishes patients with subacute cutaneous lupus erythematosus (SCLE) with major ...

Immunology

Study reveals role for oxidized mitochondrial DNA in lupus

Researchers at the Baylor Institute for Immunology Research have discovered that the neutrophils of systemic lupus erythematosus (SLE) patients release oxidized DNA from their mitochondria that can stimulate an unwanted immune ...

Immunology

Researchers find new clue in lupus autoantibody production

A signaling molecule called interferon gamma could hold the key to understanding how harmful autoantibodies form in lupus patients. The finding could lead to new treatments for the chronic autoimmune disease, said researchers ...

page 28 from 40